21st FERCAP International Online CONFERENCE

December 9-11, 2021

Hosted by the Faculty of Medicine, Public Health and Nursing

Universitas Gadjah Mada

Theme: Ethical Lessons Learned During Epidemic Outbreaks

Conference Announcement and Call for Abstracts

Conference Schedule

December 9-10 2021 Thursday – FridayConference Proper
December 11, 2021  SaturdayFERCAP Recognition Program 

It has been two years since the outbreak of the COVID 19 pandemic that affected all regions of the world.  While not a single country was prepared to meet the challenges of the global pandemic, each country has adopted its own contingency measures to protect its population from the ravaging effects of the pandemic.  There was a race among medical scientists to develop effective drugs and vaccines to contain contagion and public health measures were adopted to prevent its spread.  The pandemic also wreaked havoc on the global economy with hundreds of thousands of the population losing their jobs and inevitably causing an economic recession.  It created a global public emergency that required coordinated global surveillance and monitoring systems as individual countries shared their experiences and best practices with each other.  

The FERCAP conference will seek to describe the ethical lessons learned from the best practices derived from the health systems initiatives to address the COVID 19 pandemic, the ethical approaches used to implement scientific and medical innovative interventions, the public health measures that were enforced, and the community engagement experiences that empowered the target populations.

Call for Abstract Submission

Presentation abstracts (approximately 300 – 500 words) may be submitted to cristina.torres@yahoo.com; atoynavarro@yahoo.com  and/or triwibawa@ugm.ac.id; madarinajulia@ugm.ac.id on or before October 31, 2021 on any of the suggested topics below:

  • International/ national policies, regulations, guidelines and practices related to ethical issues during an epidemic outbreak or a public health emergency 
  • Ethical controversies related to COVID 19 treatment and prevention
  • Addressing ethical challenges in research during an epidemic
    • Genetic analysis of the virus/ laboratory research
    • Stages of investigational drug development
    • Diagnostic tool development
    • Vaccine development
    • Use of blood, plasma and other biologic to treat Covid-19
    • Traditional/ complementary medicine
    • Ethical issues in the conduct of clinical trials during a pandemic
    • Public health research during a public health emergency
    • Socio-behavioral research during an epidemic outbreak
    • Community engagement 
  • Ethical issues in clinical care
  • International collaboration during a pandemic
  • Communication and health promotion during an epidemic outbreak
  • Scientific integrity in publication
  • Ethics in surveillance and data analytics
  • Best practices of research ethics committees during an epidemic
    • Ethical issues in reviewing investigational new product applications for Covid19
    • Reviewing multi-country clinical trials during epidemic outbreaks
    • Data privacy issues during a public health emergency.
    • Data and benefit sharing during Covid-19 pandemic
    • Addressing conflicts of interest
    • Use of online platforms for ethics review
    • Improving quality of ethics review of protocols
    • Reviewing various types of informed consent (individual vs. administrative consent,  broad consent, electronic informed consent, etc.)

18th FERCAP Annual Conference

Strengthening Scientific Innovation and Ethical Assessment of Health Research

Date: November 18-21, 2018

Taoyuan, Taiwan

Conference Schedule

18 Nov. 2018 Sunday (1300 – 1700)

  • Pre-Conference Training: Ethics Review of Innovative Design

19 – 20 Nov. 2018 Monday – Tuesday

  • Conference Proper

21 Nov. 2018 Wednesday

  • FERCAP Recognition Program and General Assembly

GCP Workshop for Researchers 2018

Date: 12th & 13th June 2018

time: 9.00am

Venue: Lionel Memorial Auditorium, Sri Lanka Medical Association, No 6, Wijerama Mawatha, Colombo


Day 1: 12th June 2018


President FERCSL

Introduction to GCP, Principles. What is GCP? Need for GCP?

Prof Priyadarshani Galappaththy

Professor in Pharmacology

FM, Colombo


Role and Responsibilities of PI

Prof Priyadarshani Galappaththy

Professor in Pharmacology

FM, Colombo


Drug development process

Dr Channa Ranasinha

Senior Lecturer in Pharmacology,

FM, Kelaniya


Regulatory requirements for clinical trials and legal frame work

Mr Arjuna Pathmaperuma

Regulatory Pharmacist



Clinical Trial protocol and Investigation Brochure

Prof G R Constantine

Professor in Clinical Medicine,

FM, Colombo


Participant safety and adverse effects

Prof Shalini Sri Ranganathan

Professor in Pharmacology

FM, Colombo


Documentation and record keeping

Dr Noel Somasundaram

Consultant Endocrinologist


Day 2 – 13th June 2018

Ethics review committee – function with special ref to GCP and Clinical Trials

Dr. Panduka Karunanayake

Senior Lecturer in Clinical Medicine, FM, Colombo

Secretary ERC, FM Colombo


Informed consent

Dr Manori Gamage

Senior Lecturer, FMS, USJ


Research ethics in Clinical Trials

Prof. Chandanie Wanigatunge

Chairperson, FERCSL

Chairperson, ERC SLMA


Investigational products

Prof Shalini Sri Ranganathan

Professor in Pharmacology

FM, Colombo


Role of the sponsor & Contract Research Organization (CRO)

Prof Asitha de Silva

Senior Professor of Pharmacology,

FM, University of Kelaniya


Research Misconduct and Conflict of Interest

Dr Malik Fernando



Dilemmas in Ethics

Date: 14th May 2018

Venue: Lionel Memorial Auditorium, SLMA

Time: 9 am to 12.30 pm


8.30 – 9.00 amRegistration
9.00 – 9.15 amIntroduction and instructionsProfessor Chandanie Wanigatunge
9.15 – 10.00 amGroup work
10.00 – 10.15 amTea
10.15 – 10.45 amEstablishing registriesPresented by Group 1
Discussion lead by
Dr Jayanie Weeratne
Professor Chandanie Wanigatunge
( Sri Lanka Medical Association )
10.45 – 11.00 amEthical Issues related to studies on herbal medicinePresented by Group 2
Discussion lead by
Dr.Vajira Seneviratne
Professor Renu Wickramasinghe (Faculty of Medical Sciences, USJ)
11.00 – 11.30 amAnalysis of genomic variations and population history among two major ethnic groups and Vedda population in Sri LankaPresented by Group 3
Discussion lead by
Dr. Panduka Karunanayake (Faculty of Medicine, University of Colombo)
11.30 – 12.00 pmHIV screeningPresented by Group 4
Discussion lead by
Faculty of Medicine, University of Jaffna
12.00 – 12.30 pmStudies that involve development and validation of toolsPresented by Group 5
Discussion lead by
Prof Sureka Chackrewarthy (Faculty of   Medicine, University of Kelaniya)


Date: 15th of December 2017

Time : 2.00 pm onward

Venue : Council Room, SLMA


    1.    Welcome address by the chairperson.

    2.    Annual report of activities by the Secretary

    4.   Annual Financial Report by the Treasurer

    5.   Any other matter.

Read FERCSL Annual Report 2017 here